Crown Princess Mette-Marit of Norway is recovering in a London clinic after undergoing a successful lung transplant, the Norwegian royal household confirmed on Tuesday. The procedure, performed at the specialist Royal Brompton Hospital, was deemed necessary due to a progressive lung condition the princess has battled for years. In a brief statement, the palace described the operation as “uncomplicated” and said the 49-year-old heir to the throne is in stable condition under close medical observation.
The transplant, which involved a matched donor, underscores the severity of the pulmonary fibrosis that had increasingly constrained her public duties. London’s Royal Brompton is one of Europe’s leading centres for such procedures, and the choice of clinic reflects the high stakes of the operation. Crown Prince Haakon, her husband, has suspended all official engagements to be at her bedside.
The duration of her hospitalisation remains undisclosed, though royal sources indicate a recovery period of several weeks. The news has prompted an outpouring of public support in Norway, where the crown princess is a popular figure. Medical experts cautiously note that lung transplants carry significant risks, including rejection and infection, but the early signs are encouraging.
The palace has requested privacy for the family as the crown princess begins her rehabilitation. This development comes as a reminder of the vulnerability even within the protected world of royalty, and the reliance on advanced medical infrastructure and organ donation. The Norwegian government has been kept informed, and security protocols have been adjusted around the clinic.
For now, the focus remains on the crown princess’s recovery, with further updates expected when the palace deems it appropriate.
